Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 2 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 12275758

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  2. US 12274741

    Cattle fever tick-infestation vaccines and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  3. US 12275786

    Anti-thyroglobulin t cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  4. US 12268737

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  5. US 12269872

    Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  6. US 12269155

    Multivalent vaccines for rabies virus and coronaviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  7. US 12268700

    3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  8. US 12270814

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  9. US 12258372

    Recombinant vaccine against Marek's disease and Newcastle disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  10. US 12251432

    Biomarkers and immunogenic compositions for filarial parasites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  11. US 12239654

    Compounds and methods for treating neurological and cardiovascular conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted
  12. US 12233124

    Recombinant metapneumovirus f proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  13. US 12233051

    Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  14. US 12227554

    Methods for selectively expanding cells expressing a TCR with a murine constant region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  15. US 12221627

    Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  16. US 12215164

    Immunotoxins with albumin binding domain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  17. US 12215349

    Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  18. US 12214031

    Mannheimia haemolytica vector

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  19. US 12210017

    Peptides representing epitopes from filoviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  20. US 12201658

    Viral gene therapy as treatment for cholesterol storage disease or disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  21. US 12202886

    Neutralizing antibodies to GP120 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  22. US 12202902

    FLT3-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  23. US 12195724

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  24. US 12188005

    NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted